Rovin Capital Bio Rad Laboratories, Inc. Transaction History
Rovin Capital
- $270 Million
- Q3 2024
A detailed history of Rovin Capital transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rovin Capital holds 1,999 shares of BIO stock, worth $675,362. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,999Holding current value
$675,362% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$644 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$524 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$440 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$367 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$241 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.32B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...